cover illustration Gamma camera images showing tumor targeting of the radiolabeled humanized anti-CEA hT84.66 mAb. [111In]DOTA-hT84.66 mAb was injected intravenously into an athymic mouse bearing an LS174T human colorectal cancer xenograft. Specific tumor targeting and retention as well as normal organ clearance were demonstrated over time: day 0 (left), day 2 (center) and day 4 (right). For further details, see Yazaki et al pages 481-489.
[Table of Contents]